Boston Scientific spends $70 million on MinTec
This article was originally published in Clinica
Boston Scientific, the US manufacturer of minimally invasive products, has purchased privately-owned MinTec for $70 million in cash. MinTec, which has its headquarters in the Bahamas, is developing stent graft technology for the repair of abdominal aortic aneurysms, peripheral aneurysms and peripheral vascular occlusive disease. Boston says it has been working with MinTec for some time on the development of a bifurcated stent graft and delivery system for the repair of AAAs using the technology of its Meadox division.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.